We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Virus Filters Developed for Biomedical Applications

By LabMedica International staff writers
Posted on 22 Jul 2009
In biomedicine and biotechnology, the smallest, complex, compound-sample quantities must be effectively processed. More...
Microsystems with new mechanisms of action for pumping, filtering, and separating will manage this task with great efficiency in the future.

Providing viable evidence of viruses in human blood presently requires time- and labor-intensive biomolecular procedures. Established methods are particularly hard pushed to produce evidence when the viral burden is very low, as for example during a phase of therapy. This could soon change: while developing new types of micro-pumps without movable parts, scientists from the Fraunhofer Institute for Biomedical Engineering IBMT (St. Ingbert, Germany) came across an unexpected phenomenon: stable turbulence structures formed in the microscale pump channels.

The nano- and microparticles actually intended to verify the pump effect accumulated in large quantities in the channels. The vortex patterns completely filled the whole microchannel, creating a virtually 100% trap for the particles that followed the generated flow profile, although there is a very large cross-section to flow through. "The development of flow vortices is nothing unusual on the macroscopic scale. However, in microchannels the flow lines almost run in parallel,” explained Dr. Richard Stein from the IBMT. "The question, therefore, was, how is it possible for vortices to be formed from this, which were sufficiently stable and effective for the concentration of nanoparticles?”

Experiments were not successful in determining the parameters by which the filter effect could be systematically controlled. This is because in the pump mechanism examined, high-frequency electrical traveling waves propel the fluid into the microchannels, superimposing a large number of effects on one another.

"In order to understand the complex procedures, there was a clear need for a theoretical description. My task was to describe the surprising phenomenon and to make it controllable,” noted Dr. Stein. In his thesis "Mathematical modeling, analysis, and numerical simulation of electrothermally driven micropumps.”

Richard Stein succeeded in explaining the development of the vortex pattern. To this end, he had to factor in all the relevant processes--of an electrical, thermal, and hydrodynamic nature--in a three-dimensional model. The findings of the project explain the observed effects completely, so that now both effective micropumps and efficient particle filters can be developed and built for many biomedical applications.

Related Links:
Fraunhofer Institute for Biomedical Engineering IBMT




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.